Canon (7751) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
27 Jul, 2026Executive summary
Achieved record second-quarter net sales, up 3.6% year-over-year, driven by strong compact and network camera sales and semiconductor lithography equipment demand.
Net sales for the six months ended June 30, 2026, rose 3.5% year-over-year to ¥2,274.5 billion, with operating profit up 7.6% to ¥230.6 billion and net income attributable to shareholders up 9.8% to ¥171.2 billion.
Operating profit rose 35.2% to 159.2 billion yen, with net income up 46.9% to 122.9 billion yen compared to the same quarter last year.
Comprehensive income surged 84.3% year-over-year, reflecting strong operational and financial performance.
Higher costs from memory prices and Middle East disruptions were offset by U.S. tariff refunds and yen depreciation.
Financial highlights
Second-quarter net sales: 1,180.9 billion yen (+3.6% YoY); first-half net sales: 2,274.5 billion yen (+3.5% YoY).
Gross profit margin improved to 52.3% in Q2 (from 46.9% YoY); operating margin rose to 13.5% (from 10.3%).
Net income margin increased to 10.4% in Q2 (from 7.3% YoY).
Basic EPS rose 16.8% to ¥197.51.
Cash and cash equivalents at period end were ¥731.9 billion, up from ¥715.2 billion a year earlier.
Outlook and guidance
Full-year 2026 net sales forecast is ¥4,800 billion (+3.8% year-over-year), with operating profit projected at ¥465 billion (+2.1%) and net income at ¥340 billion (+2.4%).
Raised full-year operating profit projection by 9.0 billion yen to 465.0 billion yen, reflecting positive FX and tariff impacts.
Dividend policy targets a payout ratio of around 40%, with annual dividends forecast at ¥160 per share.
Negative impacts from Middle East situation (−34.6 billion yen) and higher memory costs (−6.0 billion yen) expected to persist.
U.S. tariff refunds (+37.5 billion yen) and favorable FX (+34.1 billion yen) to offset cost pressures.
Latest events from Canon
- Record 1Q sales up 3.3% YoY, but profit and net income fell on higher costs and tariffs.7751
Q1 202623 Apr 2026 - Record sales and profit growth in 2025, with further gains and higher margins projected for 2026.7751
Q4 202529 Jan 2026 - Record Q2 sales and profit growth, with raised full-year outlook and strong segment results.7751
Q2 202426 Jan 2026 - Record sales and profit growth in Q3 2024, led by Printing and Imaging, with a strong full-year outlook.7751
Q3 202426 Jan 2026 - Record sales in 2024, Medical goodwill hit, but 2025 profit rebound expected.7751
Q4 202426 Jan 2026 - Record sales offset by profit pressure from tariffs; guidance lowered, dividend raised.7751
Q3 202527 Oct 2025 - Profitability improved in local currency, but full-year guidance was revised downward.7751
Q2 202524 Jul 2025 - Record Q1 sales and profit growth, led by strong imaging and printing momentum.7751
Q1 20256 Jun 2025